Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Berpu Medical Technology Co., Ltd. — Predicate Candidate Screening

9 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

209 daysmedian FDA review time
296 days90th percentile
9clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K232165Sterile Safety Hypodermic Needles for Single Use; Sterile HyBerpu Medical Technology Co., Ltd.2024-02-011950
K221045Insulin Syringes without needleBerpu Medical Technology Co., Ltd.2022-11-032090
K220061Safety Insulin SyringesBerpu Medical Technology Co., Ltd.2022-08-232250
K213158Syringe with permanently attached needleBerpu Medical Technology Co., Ltd.2022-07-212960
K213811Sterile Hypodermic Syringes for Single UseBerpu Medical Technology Co., Ltd.2022-05-121560
K212514Safety Pen Needle for Single Use, Insulin Pen NeedlesBerpu Medical Technology Co., Ltd.2022-04-292620
K181447Safety insulin needle for single useBerpu Medical Technology Co., Ltd.2019-03-122840
K180417Self-destruction Safety Syringes for Single Use; Sterile HypBerpu Medical Technology Co., Ltd.2018-08-091750
K162180Disposable Insulin SyringeBerpu Medical Technology Co., Ltd.2016-12-291470

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda